Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer
- 20 September 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (42), 6073-6083
- https://doi.org/10.1038/sj.onc.1204736
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 74 references indexed in Scilit:
- The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKBExperimental Cell Research, 1999
- Bcl-2–Mediated Drug ResistanceThe Journal of Experimental Medicine, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999
- Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAILThe Journal of Experimental Medicine, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Apoptosis by Death FactorCell, 1997